All Updates

All Updates

icon
Filter
Partnerships
Owkin expands into DACH region through partnerships for AI-driven drug discovery and development
AI Drug Discovery
Jul 3, 2024
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
AI Drug Discovery

AI Drug Discovery

Jul 3, 2024

Owkin expands into DACH region through partnerships for AI-driven drug discovery and development

Partnerships

  • AI-driven biotech unicorn company Owkin has expanded its operations in Germany, Austria, and Switzerland, following partnerships with nine leading healthcare institutions. This collaboration is aimed to enhance AI-driven precision drug discovery and development.

  • Under the collaboration, Owkin will gather and analyze medical data from these hospitals to improve patient outcomes in prostate cancer, muscle-invasive bladder cancer, and cardiovascular disease. This will enable novel biomarker discovery, anticipate treatment responses, and develop more effective individualized therapies. These partnerships also will help to strengthen Owkin's MOSAIC network, a global initiative aiming to build the world's largest spatial omics dataset in oncology.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.